戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  rat treated with N-methyl-N-nitrosourea and testosterone propionate.
2 adectomized rats that were supplemented with testosterone propionate.
3 changed after injection of 300 micrograms of testosterone propionate.
4 erone acetate (50 mg/kg/day for 21 days) and testosterone propionate (100 mg/kg/day for 3 days), grou
5 half examines the neuroprotective effects of testosterone propionate, 17-beta estradiol, and dihydrot
6                  Treatment of GDNX rats with testosterone propionate (500 microg/d, s.c., 2 d) increa
7   Both estradiol benzoate (20 microg/kg) and testosterone propionate (500 microg/kg), but not dihydro
8 -1 + UGM tissue recombinants were exposed to testosterone propionate and 17-beta-estradiol (T + E2),
9 female pups were injected with 100 microg of testosterone propionate, and male and control female pup
10                              The addition of testosterone propionate does not affect tumor incidence
11 equential regimen of cyproterone acetate and testosterone propionate, followed by a single i.v. injec
12 dly, prenatal or early postnatal exposure to testosterone propionate had no effect on adult females'
13 nd adult female rats neonatally treated with testosterone propionate on the first day after birth dis
14 ale rat pups were treated with the androgen, testosterone propionate, or the oil vehicle alone.
15 s of a high, medium, or low dose of the AAS, testosterone propionate, or the oil vehicle.
16 ngly, neonatal gonadectomy, with and without testosterone propionate replacement, was followed by fin
17 emale rats received sc injections of 1.25 mg testosterone propionate (Testos; n = 10), 0.5 mg estradi
18 yndrome (PCOS), (pregnant ewes injected with testosterone propionate (TP) (100 mg twice weekly) from
19 al males (P7-P14) received 200 micrograms of testosterone propionate (TP) 2 hours prior to death to e
20     Furthermore, it has been documented that testosterone propionate (TP) augments peripheral motoneu
21 intact breeding males by daily injections of testosterone propionate (TP) for 5 weeks.
22 hat treating neonatally castrated males with testosterone propionate (TP) in adulthood did not revers
23 ferrets (Mustela putorius furo) given either testosterone propionate (TP) or oil vehicle preferred to
24 e rats were exposed to a single injection of testosterone propionate (TP) or oil within 24 h of birth
25                     The ability of postnatal testosterone propionate (TP) to masculinize both behavio
26 n with protracted (3-week) administration of testosterone propionate (TP) to socially isolated (SI) a
27                                              Testosterone propionate (TP) treatment prevented LNCaP 1
28                                              Testosterone propionate (TP) treatment resulted in numbe
29                In this study, the ability of testosterone propionate (TP), alone or in conjunction wi
30                                              Testosterone propionate (TP), augments facial nerve rege
31 sses of steroid agonists applied (androgen - Testosterone propionate (TP), estrogen - Diethystilbeste
32 ta-estradiol benzoate (EB), or 250 microg of testosterone propionate (TP), or both EB and TP, or sesa
33 cement therapy with estradiol benzoate (EB), testosterone propionate (TP), or sesame oil (SO) vehicle
34 studied: intact, castrated, or castrated and testosterone propionate (TP)-treated normal adult male m
35                   Treatment of OVX rats with testosterone propionate (TP; 500 microg/d, s.c., 2 d) si
36                               Treatment with testosterone-propionate (TP) reveals sex-specific gene e
37                             Short-term (2 d) testosterone propionate treatment reversed the decline i
38 ied in gonadectomized rats supplemented with testosterone propionate, with 17-beta-estradiol, or with

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。